Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12188/9043
DC FieldValueLanguage
dc.contributor.authorKuzmanovski, I.en_US
dc.contributor.authorCvetkovska, E.en_US
dc.contributor.authorBabunovska, Marijaen_US
dc.contributor.authorKiteva Trenchevska, Gen_US
dc.contributor.authorBiljana Kuzmanovskaen_US
dc.contributor.authorBoshkovski, Bojanen_US
dc.contributor.authorIsjanovska, Rozalindaen_US
dc.date.accessioned2020-09-17T10:57:43Z-
dc.date.available2020-09-17T10:57:43Z-
dc.date.issued2016-05-
dc.identifier.urihttp://hdl.handle.net/20.500.12188/9043-
dc.description.abstractSurveys on mesial temporal lobe epilepsy (MTLE) repeatedly demonstrate that seizures are commonly resistant to antiepileptic drugs (AED), but patients usually came from third-level epilepsy centers, making the medically refractory population larger. The aim of our study is to evaluate patterns of seizure control and prognostic factors of general population of MTLE patients observed in clinical practice.en_US
dc.language.isoenen_US
dc.publisherElsevier BVen_US
dc.relation.ispartofClinical neurology and neurosurgeryen_US
dc.titleSeizure outcome following medical treatment of mesial temporal lobe epilepsy: Clinical phenotypes and prognostic factorsen_US
dc.typeArticleen_US
dc.identifier.doi10.1016/j.clineuro.2016.03.018-
dc.identifier.urlhttps://api.elsevier.com/content/article/PII:S0303846716300981?httpAccept=text/xml-
dc.identifier.urlhttps://api.elsevier.com/content/article/PII:S0303846716300981?httpAccept=text/plain-
dc.identifier.volume144-
item.grantfulltextnone-
item.fulltextNo Fulltext-
crisitem.author.deptFaculty of Medicine-
crisitem.author.deptFaculty of Medicine-
crisitem.author.deptFaculty of Medicine-
Appears in Collections:Faculty of Medicine: Journal Articles
Show simple item record

Page view(s)

58
checked on Apr 24, 2024

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.